Login to Your Account



Alkermes Bags Elan Drug Delivery Unit for $960M

By Nuala Moran


Tuesday, May 10, 2011
LONDON – Alkermes Inc. is acquiring the drug delivery arm of Elan plc in a cash and shares deal valued at $960 million. Of that Elan will receive $500 million cash, with the balance coming in the form of 31.9 million shares.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription